The reduction of systemic endotoxemia may be contributed in an increased expression of the insulin‐stimulate glucose uptake protein markers, AktSer473 phosphorylation, and GLUT4 protein expression together with enhancement of the pAMPK activation resulting in stimulated glucose uptake and reduced hyperglycemia subsequently. The gene discussed is SLC2A4; the disease is Hyperglycemia.